Does the pediatric endocrinologist have reasons to be concerned about toxicities, side effects, and/or complications associated with long-term corticosteroid use in the pediatric patient with CAH?

Patricia Fechner, MD

Medical Director, DSD Program
Medical Director, CAH Program
Co-Director, Turner Syndrome Clinic
Seattle Children’s Hospital
Professor of Pediatrics
University of Washington School of Medicine
Seattle, WA